Form 4 for HCAT Health Catalyst, Inc.
Accepted 2026-02-27 00:00:00 ET · period of report 2026-02-25 · accession 0001975281-26-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-27 | 2026-02-26 | HCAT | Landry Benjamin | GC | F - Tax | $1.75 | -6,317 | 399.2K | -2% | -$11.1K | |
| M | 2026-02-27 | 2026-02-25 | HCAT | Landry Benjamin | GC | A - Grant | $0.00 | +305.5K | 389.0K | +366% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-26 | F | D | 6,317 | $1.75 | 399,156 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-25 | A | A | 16,473 | $0.00 | 405,473 | D | — | — | (F2) Represents an award of 16,473 performance-based restricted units ("PRSUs") pursuant to the 2019 Plan, based upon the Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2025. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. |
| 3 | Common | Common Stock | 2026-02-25 | A | A | 289,000 | $0.00 | 389,000 | D | — | — | (F1) Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will vest in 12 equal quarterly installments beginning on March 1st 2026. |